Compare BBOT & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBOT | UWMC |
|---|---|---|
| Founded | 2016 | 1986 |
| Country | United States | United States |
| Employees | N/A | 9100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | BBOT | UWMC |
|---|---|---|
| Price | $8.70 | $3.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $24.00 | $6.66 |
| AVG Volume (30 Days) | 184.8K | ★ 18.8M |
| Earning Date | 03-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 11.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.08 |
| P/E Ratio | ★ N/A | $82.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.67 | $3.46 |
| 52 Week High | $14.87 | $7.14 |
| Indicator | BBOT | UWMC |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 34.49 |
| Support Level | N/A | N/A |
| Resistance Level | $12.36 | $5.99 |
| Average True Range (ATR) | 0.55 | 0.21 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 3.28 | 17.18 |
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.